These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30702524)

  • 1. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.
    Guerveno C; Raymond S; Metsu D; Gandia P; Izopet J; Martin-Blondel G; Delobel P
    AIDS; 2019 Mar; 33(3):593-594. PubMed ID: 30702524
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV encephalitis in a patient on antiretroviral therapy: a case report.
    Hlebowicz M; Parczewski M; Jakubowski P
    Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".
    Calcagno A; D'Avolio A; Di Perri G; Bonora S
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):e118-9. PubMed ID: 24135736
    [No Abstract]   [Full Text] [Related]  

  • 4. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.
    Cusini A; Vernazza PL; Yerly S; Decosterd LA; Ledergerber B; Fux CA; Rohrbach J; Widmer N; Hirschel B; Gaudenz R; Cavassini M; Klimkait T; Zenger F; Gutmann C; Opravil M; Günthard HF;
    J Acquir Immune Defic Syndr; 2013 Jan; 62(1):28-35. PubMed ID: 23018371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".
    Cusini A; Ledergerber B; Widmer N; Günthard HF
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):e14-5. PubMed ID: 24047974
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurosymptomatic cerebrospinal fluid escape in HIV-2: a case report.
    Kulkarni V; Kulkarni R; Parchure R
    Int J STD AIDS; 2018 Jun; 29(7):726-728. PubMed ID: 29251118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.
    Calcagno A; Simiele M; Alberione MC; Bracchi M; Marinaro L; Ecclesia S; Di Perri G; D'Avolio A; Bonora S
    Clin Infect Dis; 2015 Jan; 60(2):311-7. PubMed ID: 25281609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid HIV load in diverse clinical circumstances.
    Jenny-Avital ER; Hoffman J; Katz M; Leider J; Apfelroth S
    Clin Infect Dis; 2008 Jun; 46(12):1938-40; author reply 1940-1. PubMed ID: 18540816
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.
    Martins J; Santos E; Salgado P; Maia L; Dias D; Marta M; França M
    AIDS; 2016 Apr; 30(7):1143-4. PubMed ID: 27028145
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
    Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
    J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of HIV central nervous system persistence on pathogenesis.
    Brew BJ; Barnes SL
    AIDS; 2019 Dec; 33 Suppl 2():S113-S121. PubMed ID: 31790377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of HIV in the central nervous system.
    Valcour V; Sithinamsuwan P; Letendre S; Ances B
    Curr HIV/AIDS Rep; 2011 Mar; 8(1):54-61. PubMed ID: 21191673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of raltegravir-resistant HIV-1 in the central nervous system.
    Watanabe K; Honda M; Watanabe T; Tsukada K; Teruya K; Kikuchi Y; Oka S; Gatanaga H
    Int J STD AIDS; 2010 Dec; 21(12):840-1. PubMed ID: 21297097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating HIV Infection in the Central Nervous System.
    Calcagno A; Di Perri G; Bonora S
    Drugs; 2017 Feb; 77(2):145-157. PubMed ID: 28070871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
    Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
    Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK
    Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
    Guille M; Rousset S; Bonneville F; Mengelle C; Taoufik Y; Delobel P; Martin-Blondel G
    AIDS; 2019 Oct; 33(12):1954-1956. PubMed ID: 31490218
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing central nervous system complications associated with the human immunodeficiency virus.
    Mclauchlan D; Robertson NP
    J Neurol; 2014 Sep; 261(9):1842-5. PubMed ID: 25119844
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
    Bogoch II; Davis BT; Venna N
    J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.